ERG and Familial prostate cancer: In prostate cancer, loss of the tumor suppressor PTEN increases ERG levels by inhibiting PTEN-mediated degradation of ERG [97,98] and resulting in a cascade of events that induce cell proliferation through the Hippo pathway.